
Overview
Ian Chang is an associate in the Mergers and Acquisitions practice of Paul Hastings and is based in the firm’s New York office. He advises public and private companies, private equity sponsors, financial institutions, investors and special committees on a wide range of domestic and cross-border corporate transactions, including mergers and acquisitions, leveraged buyouts, minority investments, strategic investments, joint ventures and other complex business combinations.
His practice covers the full spectrum of M&A and private equity work. Ian has advised clients on restructuring and special situations matters, including distressed and opportunistic acquisitions, asset sales and other restructuring-driven transactions. His experience also includes deSPAC transactions, take-privates, carve-outs and exits for private equity sponsors and their portfolio companies.
Ian also advises public company clients on corporate governance matters, SEC reporting and disclosure obligations, as well as other general corporate and commercial issues.
His transactional experience covers a wide range of industries, including technology, financial services, consumer products, industrials, retail and media.
Education
- Osgoode Hall Law School, J.D., 2024
- Schulich School of Business, M.B.A., 2024
- Duke University, B.A., 2019
News
- Paul Hastings Advises Heidrick & Struggles in Completed $1.3 Billion Take-Private Transaction - December 11th, 2025
- Paul Hastings Advises ITT in Acquisition of SPX FLOW for $4.7 Billion - December 5th, 2025
- Paul Hastings Advises Goldman Sachs Alternatives as Lead Investor in SKIMS Senior Preferred Fundraising Round - November 21st, 2025
- Paul Hastings Advises Great Hill Partners and TodayTix Group in the Sale of TodayTix Group to Mari - October 20th, 2025
- Paul Hastings Advises Heidrick & Struggles in $1.3 Billion Definitive Agreement With Investor Consortium Led by Advent International and Corvex to Become a Private Company - October 6th, 2025
- Paul Hastings Advises Lenders in ZIPS Car Wash Chapter 11 Restructuring Exit - May 8th, 2025
- Paul Hastings Advises Pactiv Evergreen Inc. in Closing of $6.7 Billion Combination With Novolex - April 1st, 2025
- Paul Hastings Advises Artemis Real Estate Partners on Sale to Barings - February 18th, 2025
- Paul Hastings Advised Pactiv Evergreen Inc. in Its $6.7 Billion Combination with Novolex - December 9th, 2024